Follow the 페니트리움바이오 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 페니트리움바이오 has published 1 public disclosures. Market capitalisation: €235.9bn. The latest transaction was filed on 26 March 2026 (Other). Among the most active insiders: 현대바이오. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
페니트리움바이오 opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se enfoca en el desarrollo de soluciones biofarmacéuticas innovadoras.